Tennessee

Sixth Circuit Affirms Summary Judgment in Three Cases for Firm Client Novartis

Case | Pharmaceutical & Medical Device | August 23, 2011

In 2011, the Sixth Circuit affirmed summary judgment for Novartis in three cases, in which plaintiffs had no retained experts on the subject of specific causation, i.e., did Aredia and/or Zometa cause plaintiffs to develop osteonecrosis…

Hollingsworth LLP Defeats $19B Class Certification Claim in Aredia/Zometa MDL

Case | Class Action Defense | Products Liability & Toxic Torts | Pharmaceutical & Medical Device | October 10, 2007

In re Aredia & Zometa Prods. Liab. Litig., 3:06-MD-1760 (J.P.M.L. Dec. 3, 2008)

Case | Pharmaceutical & Medical Device | December 3, 2008

Novartis Wins Again

Case | Products Liability & Toxic Torts | Pharmaceutical & Medical Device | September 6, 2013

Three weeks before a scheduled trial, the U.S. District Court for ‎the Eastern District of Tennessee granted summary judgment for Novartis Pharmaceuticals ‎in Payne v. Novartis Pharm. Corp., No. 1:12-CV-77 (E.D. Tenn. ‎Sept. 6, 2013). Senior…

Sixth Circuit Affirms Summary Judgment Based on Statutory Presumption Created by Florida Law

Case | Pharmaceutical & Medical Device | Complex Litigation | August 23, 2011

In Emerson v. Novartis Pharm. Corp., No. 09-6273, 2011 WL 3701835 (6th Cir. Aug. 23, 2011), the Sixth Circuit affirmed a grant of summary judgment based upon a statutory presumption created by Florida law. Florida has…

Thorn v. Novartis Pharm. Corp., No. 0003:04-CV-586 (E.D. Tenn. 2005)

Case | Products Liability & Toxic Torts | Pharmaceutical & Medical Device | August 30, 2005

Ballentine v. Terminix Int’l Co., No. 94C-3300 (Consol. with Nos. 95C-813 & 98C-836), slip op. (Tenn. Cir. Ct. Aug. 27, 2004).

Case | Products Liability & Toxic Torts | August 27, 2004